Keyphrases
Novel Mechanism
100%
Novel Therapeutics
100%
Immune Checkpoint Inhibitors
100%
Bladder Cancer
100%
Resistance Mechanisms
100%
Chemotherapy
66%
Radical Cystectomy
33%
Recurrence Risk
33%
Non-muscle Invasive Bladder Cancer (NMIBC)
33%
Muscle-invasive
33%
Tumor mutation Burden
33%
Personalized Medicine
33%
Invasive Cancer
33%
Urothelial Carcinoma
33%
Common Cancers
33%
Novel Therapies
33%
Tumor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Immune Checkpoint Inhibitor
100%
Bladder Cancer
100%
Neoplasm
66%
Chemotherapy
66%
Non Muscle Invasive Bladder Cancer
33%
Tumor Invasion
33%
Recurrent Disease
33%
Malignant Neoplasm
33%
Transitional Cell Carcinoma
33%
Medicine and Dentistry
Bladder Cancer
100%
Immune Checkpoint Inhibitor
100%
Personalized Medicine
33%
Tumor Invasion
33%
Recurrent Disease
33%
Malignant Neoplasm
33%
Cystectomy
33%
Specific Tumor
33%
Non Muscle Invasive Bladder Cancer
33%
Neoplasm
33%
Transitional Cell Carcinoma
33%